Published in J Exp Med on August 01, 1993
Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med (1997) 5.56
Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood (2009) 3.46
Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med (2002) 3.35
Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med (2000) 3.20
T cell genetic background determines default T helper phenotype development in vitro. J Exp Med (1995) 3.18
Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol (2010) 3.12
gammadelta T cells: an important source of IL-17. Curr Opin Immunol (2008) 3.03
Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med (1994) 3.02
Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med (1994) 2.99
CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med (1994) 2.88
Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J Exp Med (1996) 2.62
IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci U S A (2007) 2.46
Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev (2005) 2.33
Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med (2006) 2.30
Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med (1996) 2.19
Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J Exp Med (1995) 2.17
Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med (1997) 2.17
Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med (1999) 2.05
Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun (2002) 1.99
Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun (1996) 1.93
Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med (1999) 1.88
NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity (2012) 1.84
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75
Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J Exp Med (1995) 1.74
Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J Exp Med (2000) 1.69
Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J Exp Med (1996) 1.68
Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol (1994) 1.64
Interleukin-12 in infectious diseases. Clin Microbiol Rev (1997) 1.63
Induction of natural killer cell responses by ectromelia virus controls infection. J Virol (2007) 1.62
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med (2000) 1.57
Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect Immun (2000) 1.56
ECM1 controls T(H)2 cell egress from lymph nodes through re-expression of S1P(1). Nat Immunol (2011) 1.54
Role of NK cells in early host response to chlamydial genital infection. Infect Immun (1998) 1.48
Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J Virol (2003) 1.46
Natural killer cells in infection and inflammation of the lung. Immunology (2009) 1.46
Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood (2011) 1.45
Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect Immun (1995) 1.44
Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun (1994) 1.39
Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect Immun (1995) 1.39
Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J Immunol (2008) 1.33
Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect Immun (2001) 1.33
Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect Immun (1996) 1.32
Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect Immun (2000) 1.29
Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect Immun (1996) 1.27
Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J Immunol (2009) 1.22
Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun (1994) 1.21
Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect Immun (1999) 1.21
The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. J Immunol (2009) 1.19
Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytes. J Exp Med (1994) 1.18
TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production. J Exp Med (2007) 1.17
Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc Natl Acad Sci U S A (1995) 1.16
Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J Virol (2000) 1.15
The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology. J Virol (1998) 1.13
Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling. Mol Cell Biol (2009) 1.13
Interferon-gamma (IFN-gamma)-dependent protection and synthesis of chemoattractants for mononuclear leucocytes caused by IL-12 in the lungs of mice infected with Cryptococcus neoformans. Clin Exp Immunol (1999) 1.12
Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infect Immun (2005) 1.12
Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes. Infect Immun (2002) 1.11
Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin. Immunology (2004) 1.11
Interferon gamma derived from CD4(+) T cells is sufficient to mediate T helper cell type 1 development. J Exp Med (1998) 1.09
The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol Med Microbiol (2011) 1.09
Human immunodeficiency virus and leishmaniasis. J Glob Infect Dis (2010) 1.09
Interactions between innate and adaptive lymphocytes. Nat Rev Immunol (2014) 1.08
Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med (1996) 1.08
Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection. Infect Immun (1995) 1.08
Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect Immun (1998) 1.08
Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells. Clin Exp Immunol (2003) 1.07
IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. J Clin Invest (1996) 1.05
Mechanisms of immune evasion in leishmaniasis. Adv Appl Microbiol (2013) 1.04
The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection. J Immunol (2012) 1.03
Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response. Infect Immun (1994) 1.02
Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice. Infect Immun (1995) 1.02
Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation. J Immunol (2009) 1.01
Generation of gamma interferon responses in murine Peyer's patches following oral immunization. Infect Immun (1996) 1.01
Infection with Porcine reproductive and respiratory syndrome virus stimulates an early gamma interferon response in the serum of pigs. Can J Vet Res (2006) 1.01
T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med (1995) 1.00
Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects. Front Immunol (2014) 1.00
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome. Biol Psychiatry (2007) 1.00
Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology (2004) 1.00
Signalling through NK1.1 triggers NK cells to die but induces NK T cells to produce interleukin-4. Immunology (1998) 0.99
Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei. Infect Immun (2006) 0.99
Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. Infect Immun (1997) 0.99
T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J Clin Invest (1997) 0.98
Efficient immunity against Leishmania major in the absence of interleukin-6. Infect Immun (1997) 0.96
Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major. Infect Immun (2003) 0.95
Role of natural killer cells in modulating dendritic cell responses to Leishmania amazonensis infection. Infect Immun (2008) 0.95
Protective immunity and vaccination against cutaneous leishmaniasis. Front Immunol (2012) 0.95
Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One (2012) 0.94
Intranasal infection of beige mice with Mycobacterium avium complex: role of neutrophils and natural killer cells. Infect Immun (1996) 0.94
Requirement of the initial production of gamma interferon in the generation of protective immunity of mice against Listeria monocytogenes. Infect Immun (1997) 0.94
Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα. Gene Ther (2011) 0.93
Transcriptional and epigenetic networks of helper T and innate lymphoid cells. Immunol Rev (2014) 0.93
Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice. J Virol (2002) 0.93
Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis. Clin Exp Immunol (2004) 0.93
Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation. Clin Exp Immunol (2008) 0.93
Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis. Clin Exp Immunol (1999) 0.92
Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection. Infect Immun (2007) 0.92
Neutrophils have a protective role during early stages of Leishmania amazonensis infection in BALB/c mice. Parasite Immunol (2014) 0.91
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
Biology of natural killer cells. Adv Immunol (1989) 14.77
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med (1992) 8.27
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med (1992) 7.80
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
IL-4 directs the development of Th2-like helper effectors. J Immunol (1990) 7.20
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med (1990) 6.35
The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today (1992) 5.93
Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci U S A (1992) 5.55
Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci U S A (1991) 4.95
IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol (1991) 4.83
Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol (1989) 4.70
Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol Today (1992) 4.63
Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol (1989) 4.44
IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol (1992) 4.43
Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol (1989) 4.20
Interleukin-2 augments natural killer cell activity. Nature (1981) 4.15
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science (1992) 3.71
Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol (1983) 3.58
Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol (1990) 3.56
Specific assays for cytokine production by T cells. J Immunol Methods (1989) 3.55
Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med (1978) 3.31
Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. J Immunol (1993) 3.25
An analysis of the murine NK cell as to structure, function and biological relevance. Immunol Rev (1979) 3.15
A sensitive immunochemical assay for biologically active MuIFN-gamma. J Immunol Methods (1987) 2.89
Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J Immunol (1985) 2.87
Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev (1991) 2.85
The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today (1991) 2.48
Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol (1982) 2.47
Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med (1989) 2.21
Introduction of "natural" killer' cells by BCG. Nature (1976) 1.88
Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. J Immunol (1983) 1.72
Increase in NK cell number and turnover rate during acute viral infection. J Immunol (1983) 1.65
Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis. J Immunol (1992) 1.64
Differences in susceptibility of various mouse strains to haemoprotozoan infections: possible correlation with natural killer activity. Parasite Immunol (1980) 1.48
Lymphokine-activated killer cells, natural killer cells and cytokines. Curr Opin Immunol (1991) 1.47
Analysis of the time course of IFN-gamma mRNA and protein production during primary murine listeriosis. The immune phase of bacterial elimination is not temporally linked to IFN production in vivo. J Immunol (1991) 1.40
Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J Immunol (1986) 1.39
IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. J Immunol (1988) 1.38
The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J Immunol (1988) 1.38
Leishmaniasis in beige mice. Infect Immun (1982) 1.36
Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur J Immunol (1993) 1.34
Resistance to murine cutaneous leishmaniasis is mediated by TH1 cells, but disease-promoting CD4+ cells are different from TH2 cells. Eur J Immunol (1990) 1.29
Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect Immun (1992) 1.29
Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes. J Immunol (1986) 1.28
Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. II. "Specificities" of the natural killer cells. J Immunol (1979) 1.24
Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages. J Leukoc Biol (1985) 1.23
A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J Immunol (1991) 1.19
An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice. Int J Cancer (1978) 1.13
Participation of natural killer cells in the recovery of mice from visceral leishmaniasis. Cell Immunol (1985) 1.04
Spontaneous lytic activity against allogeneic tumor cells and depression of specific cytotoxic responses in mice infected with Trypanosoma cruzi. J Immunol (1981) 0.95
Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells. J Natl Cancer Inst (1977) 0.92
Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse. Int J Cancer (1979) 0.88
Natural killer activity in experimental cutaneous leishmaniasis. Int Arch Allergy Appl Immunol (1984) 0.84
Regulation of human natural cytotoxicity by IgG--I. Characterization of the structural site on monomeric IgG responsible for inhibiting natural killer cell activity. Mol Immunol (1987) 0.83
Regulation of natural killer cell production in bone marrow of mice: no evidence for negative feedback control. Nat Immun (1992) 0.81
The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science (1994) 4.38
HIV prevention and family planning: integration improves client services in Jamaica. Aidscaptions (1995) 4.02
Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol (1995) 3.76
Sarcoidosis and its neurological manifestations. Arch Neurol (1985) 3.47
A randomised controlled trial of abdominal versus laparoscopic sacrocolpopexy for the treatment of post-hysterectomy vaginal vault prolapse: LAS study. Int Urogynecol J (2012) 3.36
Who asks permission for an autopsy? J R Coll Physicians Lond (1990) 3.26
Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev (1991) 2.85
IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol (1995) 2.72
Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J Immunol (1987) 2.43
Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci U S A (1990) 2.37
The role of interleukin 12 in the immune response, disease and therapy. Immunol Today (1994) 2.24
Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol Today (1991) 2.13
Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun (1993) 2.00
Effect of gestational age and intrauterine nutrition on plasma transferrin and iron in the newborn. Arch Dis Child (1975) 1.97
T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol (1993) 1.92
TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science (1993) 1.89
Urinary lysozyme, ribonuclease, and low-molecular-weight protein in renal disease. Lancet (1968) 1.87
The development of cadmium-induced proteinuria, impaired renal function, and osteomalacia in alkaline battery workers. Q J Med (1969) 1.80
Maternal factors in neonatal hypocalcaemia: a study in three ethnic groups. Br Med J (1971) 1.70
Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc Natl Acad Sci U S A (1995) 1.59
IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J Immunol (2000) 1.54
Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol (1996) 1.45
IL-12 is required to maintain a Th1 response during Leishmania major infection. J Immunol (2000) 1.45
The treatment of tetanus with intrathecal baclofen. Anaesth Intensive Care (2000) 1.44
The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line. Eur J Immunol (1985) 1.40
The role of the innate immune response in Th1 cell development following Leishmania major infection. J Leukoc Biol (1995) 1.40
Anonymous bounty. Nature (1970) 1.39
Microchipping tortoises. Vet Rec (1999) 1.38
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res Immunol (1996) 1.37
Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Stroke (2000) 1.35
Serum fibrin-fibrinogen degradation products associated with postoperative pulmonary embolus and venous thrombosis. Br Med J (1970) 1.34
Fetal growth and cardiovascular risk factors in Jamaican schoolchildren. BMJ (1996) 1.31
Choline monooxygenase, an unusual iron-sulfur enzyme catalyzing the first step of glycine betaine synthesis in plants: prosthetic group characterization and cDNA cloning. Proc Natl Acad Sci U S A (1997) 1.30
IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. J Immunol (1994) 1.28
Infection with Leishmania major induces interleukin-12 production in vivo. Immunol Lett (1994) 1.26
Interferon-gamma and interleukin 4 gene expression in cows infected with Mycobacterium paratuberculosis. Am J Vet Res (1998) 1.25
B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. J Immunol (1986) 1.23
Tissue predilection sites and effect of dose on Mycobacterium avium subs. paratuberculosis organism recovery in a short-term bovine experimental oral infection model. Res Vet Sci (2005) 1.20
Sustained-release theophylline: a significant advance in the treatment of childhood asthma. J Pediatr (1982) 1.15
Indochinese refugees have vastly different views and use of medical care system. Mich Med (1980) 1.12
Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol (1999) 1.11
IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunol (1997) 1.11
Control of Leishmania major infection in mice lacking TNF receptors. J Immunol (1998) 1.10
Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group. Neurology (1999) 1.10
Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect Immun (1998) 1.08
Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis. J Immunol (1983) 1.08
Recommended distributions for exposure factors frequently used in health risk assessment. Risk Anal (1994) 1.08
Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. J Immunol (1997) 1.07
Endocervical polyp in pregnancy: gray scale and color Doppler images and essential considerations in pregnancy. Ultrasound Obstet Gynecol (2005) 1.07
Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection. J Immunol (1999) 1.05
Evidence for early oxidative stress in acute pancreatitis. Clues for correction. Int J Pancreatol (1995) 1.05
Proceedings: Nutritional value of whey protein and curd protein in the low birthweight baby. Arch Dis Child (1976) 1.05
TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens. J Immunol (1999) 1.04
The research in semantics behind the OpenLabs coding system. Comput Methods Programs Biomed (1996) 1.03
Bumetanide and frusemide: a comparison of dose-response curves in healthy men. Br J Clin Pharmacol (1978) 1.02
Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratog Carcinog Mutagen (1996) 1.02
Multiple anthelmintic resistance in sheep. Vet Rec (2002) 1.01
The treatment of neurosarcoidosis with cyclosporine. Arch Neurol (1992) 1.00
A second-generation YAC contig map of human chromosome 3. Nature (1995) 1.00
Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol (1993) 0.99
Plasma alkaline ribonuclease (EC 3.1.4.22) and nitrogen retention in low-birth-weight infants. Br J Nutr (1978) 0.98
Sensory dysfunction associated with repetitive strain injuries of tendinitis and focal hand dystonia: a comparative study. J Orthop Sports Phys Ther (1996) 0.98
Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infect Immun (2001) 0.97
Spontaneous retropharyngeal haematoma in a parathyroid adenoma. Aust N Z J Surg (1998) 0.96
Il-12: keeping cell-mediated immunity alive. Scand J Immunol (2001) 0.96
Infants with cystic fibrosis: pulmonary function at diagnosis. Pediatr Pulmonol (1988) 0.96
Hyaluronic acid ester in myringoplasty. J Laryngol Otol (2007) 0.95
Activated T cells induce macrophages to produce NO and control Leishmania major in the absence of tumor necrosis factor receptor p55. Infect Immun (2000) 0.95
Fatal gastrointestinal mucormycosis that invaded the postoperative abdominal wall wound in an immunocompetent host. Clin Infect Dis (1999) 0.94
A spectrum in the susceptibility of leishmanial strains to intracellular killing by murine macrophages. J Immunol (1986) 0.94
Auditory Nerve Tumours: (Section of Otology and Section of Laryngology). Proc R Soc Med (1938) 0.94
Evaluating the adequacy of maximum contaminant levels as health-protective cleanup goals: an analysis based on Monte Carlo techniques. Regul Toxicol Pharmacol (1993) 0.94
"Pushing fluids'--can current practices of maintaining hydration in hospital patients be improved? J R Coll Physicians Lond (1987) 0.93
Classification and identification of Pfiesteria and Pfiesteria-like species. Environ Health Perspect (2001) 0.93
A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate- or ranitidine-treated intensive care unit patients. Crit Care Med (1991) 0.93
Photosynthetic carbohydrate metabolism in the resurrection plant Craterostigma plantagineum. J Exp Bot (2000) 0.92
Bidentate carbenoid ester coordination in ruthenium(II) Schiff-base complexes leading to excellent levels of diastereo- and enantioselectivity in catalytic alkene cyclopropanation. Chem Commun (Camb) (2001) 0.91
Pathogenicity of Australian strains of avian infectious bronchitis virus. J Comp Pathol (2002) 0.91
Validation of a spectroscopic sensor for the continuous, noninvasive measurement of muscle oxygen saturation and pH. Physiol Meas (2013) 0.91
Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response. J Immunol (1997) 0.91
Low caloric expenditure in cardiac rehabilitation. Am Heart J (2000) 0.90
Investigation into the ability of roots of the poikilohydric plant Craterostigma plantagineum to survive dehydration stress. J Exp Bot (2003) 0.89
Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively. Clin Immunol (2001) 0.88
The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis. Eur J Immunol (1998) 0.88
Host susceptibility factors to cutaneous leishmaniasis. Front Biosci (1998) 0.88
Separation of the Baragwanath craniopagus twins. Br J Plast Surg (1991) 0.87
A randomised controlled trial of abdominal versus laparoscopic sacrocolpopexy for the treatment of post-hysterectomy vaginal vault prolapse: LAS study. Reply to comment. Int Urogynecol J (2014) 0.87
Gastric bezoars. A technique of endoscopic removal. Am J Dig Dis (1978) 0.86
Impaired macrophage leishmanicidal activity at cutaneous temperature. Parasite Immunol (1985) 0.86
Acute stroke teams: results of a national survey. National Acute Stroke Team Group. Stroke (1998) 0.85
Observations on the function of the round window. J Physiol (1940) 0.85
Germ-free mice produce high levels of interferon-gamma in response to infection with Leishmania major but fail to heal lesions. Parasitology (2005) 0.85
A proposed approach to regulating contaminated soil: identify safe concentrations for seven of the most frequently encountered exposure scenarios. Regul Toxicol Pharmacol (1992) 0.84
Production of interleukin-10 in human fracture soft-tissue hematomas. Shock (1996) 0.84
Differential requirement of CD28 for IL-12 receptor expression and function in CD4(+) and CD8(+) T cells. Eur J Immunol (2001) 0.84
Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice. Eur J Immunol (2000) 0.84
Curd and whey proteins in the nutrition of low birthweight babies. Arch Dis Child (1979) 0.83
Biologic effect of 5-fluoro-2'-deoxyuridine incorporation in L1210 deoxyribonucleic acid. Biochem Pharmacol (1983) 0.83
Hypoxia enhances cellular proliferation and inositol 1,4, 5-triphosphate generation in fibroblasts from bovine pulmonary artery but not from mesenteric artery. Am J Respir Crit Care Med (1998) 0.83
The aerobic bacterial flora of the reproductive tract of the mare. Vet Rec (1971) 0.82